PBYI
NASDAQ · Biotechnology
Puma Biotechnology Inc
$7.35
-0.18 (-2.39%)
Open$7.59
Previous Close$7.53
Day High$7.70
Day Low$7.11
52W High$7.90
52W Low$2.85
Volume—
Avg Volume276.5K
Market Cap381.18M
P/E Ratio12.25
EPS$0.61
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
-25.9% upside
Current
$7.35
$7.35
Target
$5.45
$5.45
$2.99
$5.45 avg
$6.80
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 233.82M | 233.70M | 42.11M |
| Net Income | 31.85M | 28.65M | 7.89M |
| Profit Margin | 13.6% | 12.9% | 18.7% |
| EBITDA | 50.44M | 47.89M | 13.15M |
| Free Cash Flow | — | — | 4.76M |
| Rev Growth | +0.1% | +0.1% | +7.6% |
| Debt/Equity | 0.17 | 0.17 | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |